Current Gastroenterology Reports

, Volume 14, Issue 2, pp 174–180

Managing Risks of Neoplasia in Inflammatory Bowel Disease

Inflammatory Bowel Disease (SB Hanauer, Section Editor)

DOI: 10.1007/s11894-012-0247-7

Cite this article as:
Velayos, F. Curr Gastroenterol Rep (2012) 14: 174. doi:10.1007/s11894-012-0247-7

Abstract

Inflammatory bowel disease (IBD) has been linked with a variety of intestinal and extraintestinal cancers. This review summarizes the latest literature with regard to which cancers are truly linked with IBD and which are not, the absolute and relative risks of these cancers, how medications commonly prescribed for IBD affect this risk, and finally strategies for managing these risks. Physicians and health professionals may find this information useful for counseling and educating patients as well as for improving patient care.

Keywords

Non-melanoma skin cancerCervical cancerCervical dysplasiaSmall bowel adenocarcinomaColorectal cancerLymphomaThiopruineAnti-TNF5-aminosalicylic acid

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.University of California, San Francisco, Center for Crohn’s and ColitisSan FranciscoUSA